Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

AIMS: Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Heart Fail
Main Authors: Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, van Paassen, Pieter, van Empel, Vanessa P.M., Heymans, Stephane R.B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2021
Assuntos:
Focus on Myocarditis, Cardiomyopathy and Amyloidosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048650/
https://ncbi.nlm.nih.gov/pubmed/33347677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2082
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados